A study in 2010 conducted the evaluation of the risk of the PNPLA3 rs738409 polymorphism associated with NAFLD, and suggested that the additive genetic model could best explain the effect of rs738409 on the susceptibility to develop NAFLD [6]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.